Clinical Trial Update: Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study assessing a single dose of caspofungin in patients with liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: Erasme University Hospital | Conditions: Bacterial Infections and Mycoses, Liver Disease | Phase 4 | Status: COMPLETED